Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$271,883
-$28,041 QoQ
Shares Held
2,152
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,725
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WATERS PARKERSON & CO., LLC holds $91,644,016 across 10 Drug Manufacturers - General names. GILD ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
344,962 | $44,327,617 | |
| 2 | JNJ |
Johnson & Johnson
|
109,533 | $27,818,096 | |
| 3 | LLY |
ELI LILLY & Co
|
10,667 | $12,794,320 | |
| 4 | PFE |
Pfizer Inc
|
96,842 | $2,331,955 | |
| 5 | AMGN |
Amgen Inc
|
4,137 | $1,498,090 | |
| 6 | ABBV |
AbbVie Inc.
|
5,719 | $1,439,129 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,037 | $693,571 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,152 | $271,883 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,883 | 2,152 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $299,924 | 2,152 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $264,136 | 2,152 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $238,872 | 2,152 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $238,592 | 2,152 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $241,131 | 2,152 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||